Marketing Focus: the shift from treatment to prevention

Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene Dr Graham Leask and Stewart Adkins...

Marketing Focus: helping modern marketeers to thrive

PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...

MHRA calls for “right first time” approach to advertising

The MHRA is to take steps to protect against misleading medicines advertising messages as some breaches in regulations were exposed in a new report.

Marketing award for Schering-Plough

Schering-Plough has achieved success at this year’s UK Marketing Excellence Awards, receiving the award for best medical supplier. The company fought off competition from 3M...

Takeda campaign scoops marketing award

Takeda scored a double achievement at this year’s Pharmaceutical Marketing Excellence Awards (PMEA) by winning the Marketing Campaign of the Year award and being...

The NHS and healthcare marketing

David Thorp, Director of Research and Professional Development at the Chartered Institute of Marketing, describes how healthcare marketers can help NHS trusts to achieve...

Affective marketing with h:)mour

  Many of the most memorable ad campaigns around tend to be funny. Advertisers use this strategy to attract customers to their product. Audiences like...

Partners for success

“A successful marketing partnership can be the jewel in the crown of a company’s strategic plan. Such partnerships demand sustained commitment and effort from...

Devolved Nations – Making a difference to Sales Strategy?

PHARMACEUTICAL COMPANIES operating within the UK are now faced with the need to work within the four different healthcare systems operating within England, Scotland,...

Partnerships

the selling route of choice for the NHS Creating partnerships with the NHS is a favoured route for selling. It involves finding out what...

Latest articles

NHS trusts face worryingly high levels of senior vacancies

Why is high turnover among board-level roles make a negative impact on the performance of NHS trusts?

Triumph for Roche’s flu drug in phase III study

Roche has announced that the phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications...

Leading Alzheimer’s Disease scientist joins NeuroCog Trials

Dr. Kathleen Anne Welsh-Bohmer, a specialist in Alzheimer’s Disease research, has joined the scientific leadership team at NeuroCog Trials (NCT) as the Vice President...